ProKidney director plans sale of 675K shares

ProKidney Corp. (PROK) is the issuer for a notice of proposed sale of restricted or control securities under Rule 144.

Rhea-AI Filing Summary

ProKidney Corp. (PROK) is the issuer for a notice of proposed sale of restricted or control securities under Rule 144. Director Brian Pereira, through the Brian Pereira 2012 Trust, has filed to sell 675,235 shares of ProKidney common stock that were acquired on January 17, 2022 for cash. Merrill Lynch Pierce Fenner & Smith is listed as the broker, and a prior sale of 27,826 common shares on August 18, 2026 for $38,154.23 is also reported.

Key Figures

Shares noticed for sale: 675,235 shares Recent shares sold: 27,826 shares Proceeds from recent sale: $38,154.23 +2 more

5 metrics

Shares noticed for sale 675,235 shares Common stock to be sold under Rule 144, acquired January 17, 2022

Recent shares sold 27,826 shares Common stock sold on August 18, 2026 during past three months

Proceeds from recent sale $38,154.23 Aggregate price for 27,826 shares sold on August 18, 2026

Issuer phone number 8669554394 Contact phone for ProKidney Corp.

Date of notice 08/18/2026 Filing date of the Rule 144 notice

Key Terms

Rule 144, restricted or control securities, Irrev Trust

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted or control securities financial

"notice of proposed sale of restricted or control securities under Rule 144"

Irrev Trust financial

"Sunita Pereira, ttee Brian Pereira 2012 Irrev Trust"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing mean for ProKidney Corp. (PROK)?

The filing reports that a ProKidney Corp. director, via a trust, intends to sell 675,235 restricted or control shares under Rule 144. It is a disclosure of a potential resale, not an issuance of new shares by ProKidney.

How many ProKidney (PROK) shares are covered by this Rule 144 notice?

The notice covers 675,235 shares of ProKidney common stock. These shares were acquired on January 17, 2022 for cash and are now being noticed for potential sale under Rule 144.

Who is the selling security holder in this ProKidney (PROK) Form 144?

The selling security holder is Brian Pereira, a director of ProKidney, acting through the Brian Pereira 2012 Trust. The signature is provided by Sunita Pereira as trustee of the Brian Pereira 2012 Irrevocable Trust.

What recent ProKidney (PROK) share sales are disclosed in this Form 144?

The filing discloses that on August 18, 2026, 27,826 shares of ProKidney common stock were sold for an aggregate price of $38,154.23. This sale is reported as having occurred during the past three months.

Which broker is listed for the planned ProKidney (PROK) share sale?

The broker listed is Merrill Lynch Pierce Fenner & Smith, with an address at 100 Federal St, 12th Floor, Boston, MA 02110. The shares covered are ProKidney common stock traded on NASDAQ.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/18/2026 - 04:43 PM EDT Accepted by SEC EDGAR 08/18/2026 - 04:42 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001298146
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Prokidney Corp
SEC File Number
Address of Issuer	3929 Westpoint Blvd., Suite G Winston-Salem NORTH CAROLINA 27103
Phone	8669554394
Name of Person for Whose Account the Securities are To Be Sold	Brian Pereira
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch Pierce Fenner and Smith 100 Federal St 12th Fl Boston MA 02110	675235	945329	208926941	08/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/17/2022	Purchase of Shares	ProKidney Corp			675235	01/17/2022	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Brian Pereira C/O Prokidney Corp 3929 Westpoint Blvd., Suite G Winston-Salem NC 27103	Common	08/18/2026	27826	38154.23

144: Remarks and Signature

Remarks	Brian Pereira 2012 Trust
Date of Notice	08/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Sunita Pereira, ttee Brian Pereira 2012 Irrev Trust
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)